Omega Flex Announces Special Dividend to Shareholders

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Omega Flex Announces Special Dividend to Shareholders

MIDDLETOWN, Conn., Dec. 10, 2014 (GLOBE NEWSWIRE) -- Omega Flex, Inc. (the "Company") (Nasdaq: OFLX ) today announced that the Board of Directors declared a special dividend of $.49 per share payable on January 5, 2015 to shareholders of record on December 22, 2014.  In declaring this special dividend, the Board has restated its dividend policy of reviewing the cash needs of the Company from time to time, and based on results of operations, financial condition and capital expenditure plans, as well as such other factors as the Board of Directors may consider relevant, determine on a quarterly basis whether to declare a dividend.

Kevin R. Hoben, President and CEO of Omega Flex, Inc., stated, "We are very pleased to be in a position to pay a special dividend to the shareholders. Given the company's excellent performance so far this year, combined with its strong balance sheet and cash flow, the board has reviewed the cash needs of the company and determined that it is appropriate to return some cash to the shareholders. The company continues to have adequate liquidity to meet its operating expenses and capital investment."

This news release contains forward-looking statements, which are subject to inherent uncertainties which are difficult to predict, and may be beyond the ability of our control.

Certain statements in this news release constitute forward-looking statements with the meaning of the Private Securities Litigation Reform act of 1995, that are not historical facts but rather reflect our current expectations concerning future results and events. The words "believes," "expects," "intends," "plans," "anticipates," "hopes," "likely," "will," and similar expressions identify such forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause the actual results, performance or achievements of the Company (including its subsidiaries and affiliates) or industry results, to differ materially from future results, performance or achievements expressed or implied by such forward-looking statements.

Readers are cautioned not to place undue reliance on these forward-looking statements which reflect management's view only as of the date of this news release. We undertake no obligation to publicly release the result of any revisions to these forward-looking statements which may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, conditions or circumstances.

Kevin R. Hoben (860) 704-6820

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 4

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 5

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 3

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 3

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 7

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 3

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 2

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading

Top 5 Most Recently Viewed Articles

Tilray Brands Achieves Exceptional Performance in Q1 2025

Updated Category News Views 226

Tilray Brands Delivers Record Q1 Revenue Tilray Brands (NASDAQ: TLRY) has announced an impressive net revenue of $200 million for its first fiscal quarter, showcasing a remarkable 13% increase from the previous year. The significant boost can largely be attributed to the exponential growth within its beverage sector, including both traditional craft beers and innovative...

Continue Reading
Exor N.V. Announces Impressive Growth and Strategic Moves

Updated Category News Views 361

Exor N.V. Reports Robust Year-End Performance Exor N.V. has once again demonstrated significant growth and strategic financial management through its latest annual results. The company reported an impressive 9% growth in Net Asset Value (NAV) per share for the fiscal year, reaching €38.2 billion by year-end. This financial achievement reflects Exor's robust operational...

Continue Reading
Integral Ad Science Faces Legal Challenge – Join the Action

Updated Category News Views 102

Integral Ad Science Holding Corp. Faces Securities Fraud Allegations Levi & Korsinsky, LLP is reaching out to the investors of Integral Ad Science Holding Corp. (NASDAQ: IAS), as there is an ongoing class action securities lawsuit that could allow affected investors to recover losses. Understanding the Class Action Details This class action lawsuit aims to represent those...

Continue Reading
Innovative Oncology Solutions Unveiled by Powered Research

Updated Category News Views 132

Expanding Horizons: Powered Research's New Oncology Services For over a decade, Powered Research has earned its reputation as a premier preclinical contract research organization (CRO), particularly in the field of ophthalmology. Today, the company takes a monumental step forward by launching an extensive suite of oncology preclinical services. This new direction is set...

Continue Reading
Discover Why Jim Cramer Recommends Dominion Energy Stock

Updated Category News Views 65

Jim Cramer Sees Potential in Dominion Energy In a recent episode of CNBC's programming, well-known financial commentator Jim Cramer highlighted Dominion Energy, Inc. (D) as a promising buy. He stated, "We need cheap power," which underscores the increasing demand for affordable energy solutions in today's unpredictable market landscape. Analyst Ratings for Dominion Energy...

Continue Reading